期刊文献+

广东省2016年细菌耐药性监测及动态分析 被引量:9

Antimicrobial resistant surveillance in Guangdong in 2016
下载PDF
导出
摘要 目的统计分析广东省细菌耐药监测网2016年度细菌分布及耐药情况,为我省各单位合理应用抗菌药物提供依据。方法各单位严格按照监测要求,进行目标菌株鉴定,采用标准纸片扩散法或自动化仪器检测法测定监测药物对细菌敏感性,用WHONET 5.6软件进行数据分析。结果共有69家医院的218480株非重复细菌药敏试验信息纳入研究,包括革兰阴性菌150082株(68.7%)和革兰阳性菌68398株(31.3%)。革兰阳性菌中葡萄球菌属细菌占59.9%,其中耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus, MRSA)检出率和耐甲氧西林凝固酶阴性葡萄球菌(methicillin resistant coagulasenegative staphylococci, MRCNS)菌株分离率分别为36.5%(8000/21906)和79.6%(13972/17535)。肠球菌属中粪肠球菌对多数测试抗菌药物(除了利奈唑胺和米诺环素外)的耐药率均显著低于屎肠球菌,两者对万古霉素耐药株分别为0.3%和1.5%。青霉素耐药的肺炎链球菌比例为2%。革兰阴性菌中分离率前3位分别为大肠埃希菌(31.1%)、克雷伯菌属(16.6%)和铜绿假单胞菌(15.2%)。大肠埃希菌对喹诺酮类药物耐药率高达44.6%以上,对头孢曲松和头孢噻肟的耐药率在52.3%以上。肺炎克雷伯菌对亚胺培南和美罗培南耐药率分别为3.8%和5.2%。铜绿假单胞菌对碳青酶烯类、氨基糖苷类、哌拉西林/三唑巴坦、头孢吡肟和头孢他啶等各种常用抗菌药物耐药率均在17%以下。鲍曼不动杆菌对大多数药物耐药率超过48.6%,其中对亚胺培南和美罗培南耐药率分别为60.4%和67.8%。2012—2016年本网各年监测数据比较,除耐药鲍曼不动杆菌(cabapemne resistant Acinetobacter baumannii,CRAB)呈缓慢上升外(从46.1%到60.4%),其余常见耐药菌保持稳定水平,肺炎克雷伯菌对亚胺培南耐药率呈低水平波动,介于2.3%~5.0%。结论近年我省细菌耐药菌的构成比以及常见临床分离菌株耐药水平基本持于平稳� Objective To explore the bacterial drug resistance and its epidemic tendency in 2016 from the members of antimicrobial resistant surveillance of Guangdong province, and to guide the clinicians touse antimicrobial drugs rationally. Methods All the objective bacterial isolates were collected and identified by the unified protocol, and then the susceptibility data were analyzed by software WHONET 5.6. Results 218,480 bacterial isolates and their antibacterial susceptibility data were collected from all the 69 members of Antimicrobial Resistant Surveillance Network, which included 150,082 (68.7%) Gram-negative bacterial isolates and 68,398(31.3%) Gram-positive bacterial isolates. The detection rate of methicillin resistant Staphylococcus aureus (MRSA) and coagulase negative staphylococci (MRCNS) were 36.5% and 79.6% respectively. The prevalence of drug-resistant Enterococcusfaecalis was much lower than Enterococcusfaecium in most antimicrobial agents (except linezolid and minocycline), while 0.3% E. faecalis and 1.5% E. faecium were resistant to vancomycin. 2.0% penicillin resistant Streptococcus pneumoniae were detected in this study. The top three populations of Gram-negative bacterial isolates were E. coli (31.1%), Klebsiella (16.6%) and P. aeruginosa (15.2%), respectively. E.coli had high resistance rates to quinolones (44.6%) and cefotaxime(52.7%). The resistance rates of Klebsiella pneumoniae to imipenem and meropenem were 3.8% and5.2%, respectively. The resistant rates of P. aeruginosa to carbapenems, aminoglycosides, piperacillin/tazobactam, cefepime and ceftazidime were under 17.0%. The resistance rates of A. baumannii to most tested drugs were above 48.6%. The resistant rates of A. baumannii to imipenem and meropenem were 60.4% and 67.8%, respectively. Compared with the data from 2012 to 2016, most of organisms remained stable with low drug resistance except of CRAB, of which the resistant rate increased from 46.1% to 60.4%. Especially, the resistance rate of Klebsiel
作者 李晓雨 马明葱 谭云芳 唐翔 肖书念 卓超 Li Xiao-yu;Ma Ming-cong;Tan Yun-fang;Tang Xiang;Xiao Shu-nian;Zhuo Chao(The First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120)
出处 《中国抗生素杂志》 CAS CSCD 2018年第10期1263-1270,共8页 Chinese Journal of Antibiotics
关键词 细菌耐药性监测 耐药率 细菌感染 Bacterial resistance surveillance Resistance rate Bacterial infection
  • 相关文献

参考文献3

  • 1胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,吴玲,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍.2015年CHINET细菌耐药性监测[J].中国感染与化疗杂志,2016,16(6):685-694. 被引量:392
  • 2温朝阳,方怡,邢丽珊,张薇.MRSA医院感染控制的效果分析[J].实用医学杂志,2011,27(22):4054-4056. 被引量:12
  • 3徐安,卓超,苏丹虹,胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,孙自镛,陈中举,倪语星,孙景勇,胡志东,李金,张朝霞,季萍,王传清,王爱敏,杨青,徐元宏,沈继录,单斌,杜艳,张泓,孔菁,魏莲花,吴玲,谢轶,康梅,胡云建,艾效曼,俞云松,林洁,黄文祥,贾蓓,禇云卓,田素飞,韩艳秋,郭素芳.2005-2014年CHINET克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2016,16(3):267-274. 被引量:122

二级参考文献28

  • 1Gould F K, Brindle R, Chadwick P R, et al. Guidelines (2008)for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA)infections in the United Kingdom [J]. J Antimicrob Chemother,2009, (63):849-861. 被引量:1
  • 2Dan Ferber. Microbiology:triple-threat microbe gained powers from another bug [J]. Science,2003, (302):1488. 被引量:1
  • 3Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing [S].Twenty- Fourth Informational Supplement,2014,M100-S24. 被引量:1
  • 4Pifzer Inc.Tygacil? Product Insert.Philadelphia,PA,2013[Z/OL].[2015-04-201.http://www.pfizerpro.com/hcp/tygacil. 被引量:1
  • 5MAGIORAKOS AP,SRINIVASAN A,CAREY RB,et al.Multidrug-resistant,extensively drug-resistant and pandrug- resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance [J].Clin Microbiol Infect,2012,18(3):268-281. 被引量:1
  • 6SHON AS,BAJWA RP,RUSSA TA,et al.Hypervirulent (hypermucoviscous) Klebsiella pneumoniae:a new and dangerous breed[J].Virulence,2013,4(2):107-118. 被引量:1
  • 7LIU YM,LI BB,ZHANG YY,et al.Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in China's Mainland[J].Antimicrob Agents Chemother,2014,58(9):5379-5385. 被引量:1
  • 8TSAKRIS A, POULOU A,THEMELI-DIGALAKI K,et al.Use of boronic acid disk tests to detect extended- spectrum beta- lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae[J].J Clin Microbiol,2009,47(11):3420-3426. 被引量:1
  • 9CHONG Y,ITO Y,KAMIMURA T.Genetic evolution and clinical impact in extended-spectrum p-lactamase-producing Escherichia coli and Klebsiella pneumoniae[J].Infect Genet Evol,2011,11(7):1499-1504. 被引量:1
  • 10CURELLO J,MACDOUGALL C,et al.Beyond susceptible and resistant,part II:treatment of infections due to gram-negative organisms producing extended-spectrum p_lactamases[J].J Pediatr Pharmacol Ther,2014,19(3):156-164. 被引量:1

共引文献503

同被引文献82

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部